Abstract
The eight Asian countries covered in this report represent a total market of
588 million people and a combined GDP of US$2.8 trillion in 2008. Each country
report provides a comprehensive analysis of the pharmaceutical market,
including five-year market forecasts. For each country you will receive 4
completely updated reports sent quarterly, plus comprehensive report sent
annually.
The eight Asian countries covered in this service represent a total market of
588 million people and a combined GDP of US$2.8 trillion in 2008
Business opportunities in Asian pharmaceutical markets are very different from
a few years ago. The traditional tiger economies, characterised by economic
growth, free market environment, developed industry and investment in health
and health infrastructure have had a long haul back from the financial
instability and economic downturn in the 1990' s.
Tiger Cubs?
At the same time, markets that had hitherto excited little industry or
investor interest, have emerged as real areas of opportunity for suppliers and
service companies alike. Diverse influences - from deregulation and better
trade links to improved access and the rise of medical tourism - are seeing
markets such as Malaysia and Vietnam take an increasingly important role in
the region.
Sustained growth
With established western markets maturing, serious attention is being paid to
the countries where manufacturers can see significant long-term growth.
However, effective planning is vital, and impartial, thoroughly researched
business data is essential to fully appreciate the current market status as a
basis for future development.
These quarterly updated reports analyse the issues
That is why Espicom Business Intelligence has published these new management
reports The Outlook for Pharmaceuticals in South East Asia to 2013. Each
report provides individual and highly-detailed analysis of each market,
looking at the key regulatory, political, economic and corporate developments
in the wider context of market structure, service and access. The reports are
available individually or as a discounted collection, and prices include 4
completely updated reports sent quarterly plus a comprehensive annual review.
8 Markets Covered!
- Indonesia
- Philippines
- South Korea
- Thailand
- Malaysia
- Singapore
- Taiwan
- Vietnam